Comparative Pharmacology
Head-to-head clinical analysis: THIORIDAZINE HYDROCHLORIDE versus THIOTHIXENE HYDROCHLORIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: THIORIDAZINE HYDROCHLORIDE versus THIOTHIXENE HYDROCHLORIDE.
THIORIDAZINE HYDROCHLORIDE vs THIOTHIXENE HYDROCHLORIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Thioridazine is a typical antipsychotic of the phenothiazine class. It blocks postsynaptic dopamine D2 receptors in the mesolimbic system, and also has significant anticholinergic and alpha-adrenergic blocking activity. It exhibits a high affinity for D2, 5-HT2A, and alpha1-adrenergic receptors.
Thiothixene hydrochloride is a typical antipsychotic that blocks postsynaptic dopamine D2 receptors in the central nervous system (CNS), particularly in the mesolimbic and mesocortical pathways. It also has alpha-adrenergic blocking activity and weak anticholinergic effects.
Adults: Initial 50-100 mg orally three times daily, gradually increasing to maximum 800 mg/day in divided doses. Usual maintenance: 200-800 mg/day.
Initial: 2-5 mg orally 3 times daily; maintenance: 15-30 mg orally per day in divided doses; maximum: 60 mg orally per day.
None Documented
None Documented
24-36 hours for the parent drug; extended in hepatic impairment and elderly; steady-state reached in 4-7 days.
Terminal elimination half-life: 34 hours (range 25–50 hrs) in adults; clinical context: allows once-daily dosing.
Primarily hepatic metabolism with <1% excreted unchanged in urine; metabolites are excreted renally (approximately 30% of dose as metabolites) and fecally (approximately 20-30% via bile).
Renal: primarily as metabolites, <1% unchanged; fecal: minor; biliary: some metabolites excreted in bile.
Category A/B
Category C
Typical Antipsychotic
Typical Antipsychotic